Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2].
Molecular Weight:
(143.86 kDa)
Purity:
98.43
CAS Number:
[2416593-08-1]
Target:
c-Fms,JAK,STAT
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
